Tracheostomized COPD Patients and Non Invasive Mechanical Ventilation
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
- Interventions
- Other: WBC, biomarkers, TBA, chest X ray
- Registration Number
- NCT01285739
- Lead Sponsor
- Fondazione Salvatore Maugeri
- Brief Summary
The purpose of this study was to determine occurrence of ventilator associated pneumonia (VAP) in tracheostomized patients with COPD discharged in invasive mechanical ventilation (IMV) compared to patients with CPOPD discharged with tracheostomy but in non invasive mechanical ventilation (NIMV).
- Detailed Description
Acute respiratory failure due to COPD is often treated with invasive mechanical ventilation through endotracheal intubation, followed by placement of a endotracheal canula. However, invasive ventilation is at risk of infective complications and is difficult to manage at home. In particular, invasive mechanical ventilation may be associated with ventilator associated pneumonia (VAP). VAP is usually suspected when the individual develops a new or progressive infiltrate on chest radiograph, leukocytosis, and purulent tracheobronchial secretions. When possible, we tried to put these tracheotomized patients in non invasive mechanical ventilation (NIMV)to avoid VAP. This population was followed for eight consecutive years and compared with patients in invasive home mechanical ventilation (IMV).
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 247
- Clinical diagnosis of COPD
- Tracheostomy
- Need of domiciliary invasive / non invasive ventilation
- Patients with COPD weaned from invasive / non invasive mechanical ventilation
- Lack of tracheostomy
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description IMV COPD WBC, biomarkers, TBA, chest X ray Patients with chronic obstructive pulmonary disease (COPD), who underwent tracheostomy for acute respiratory failure and who were discharged in domiciliary invasive mechanical ventilation (IMV) NIMV COPD WBC, biomarkers, TBA, chest X ray Patients with chronic obstructive pulmonary disease (COPD), who underwent tracheostomy for acute respiratory failure and who were discharged with tracheostomy but in domiciliary non invasive ventilation
- Primary Outcome Measures
Name Time Method ventilator associated pneumonia (VAP) six months VAP is usually suspected when the individual develops a new or progressive infiltrate on chest radiograph, leukocytosis, and purulent tracheobronchial secretions. Therefore white cell blood (WBC)count, procalcitonine (PCT), C-reactive protein (CRP) and tracheobronchial aspirate (TBA) were collected every 6 months. Chest X ray was performed only when a clinical suspect of VAP was advanced.
- Secondary Outcome Measures
Name Time Method Care givers involvement Six months Through a dedicated questionnaire
Blood gas analysis Six months Blood gas analysis
Trial Locations
- Locations (1)
Weaning Center - Fondazione Salvatore Maugeri IRCCS
🇮🇹Montescano, Pavia, Italy